Vicore Pharma Holding AB, a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis, announces the participation in two upcoming investor meetings in June 2021.
GOTHENBURG, Sweden, June 15, 2021 /PRNewswire/ -- Vicore Pharma Holding AB (publ) (“Vicore”), a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis (IPF), today announces the participation in two upcoming investor meetings in June 2021.
Date: Wednesday, 23 June, 2021
Presentation: 16:40 CET (10:40 AM EDT)
Event and registration: NewYorkBIO/NYSE Emerging Biotech Company Showcase
CEO Carl-Johan Dalsgaard will present an overview of the company’s business strategy at the joint NewYorkBIO and New York Stock Exchange (NYSE) Emerging Biotech Company Showcase to be held virtually on 23 June 2021. The presentation is followed by a Q&A session.
Date: Tuesday, 29 June 2021
Presentation: 14.30 CET (8:30 AM EDT)
Event and registration: Nordic Biotech Summit
CEO Carl-Johan Dalsgaard will also present the company’s business strategy at the Nordic Biotech Summit organized by LifeSci Advisors on 29 June 2021. The meeting will take place virtually. The presentation is followed by a Q&A session and Carl-Johan and CFO Hans Jeppsson will be available for one-to-one investor meetings throughout the day.
For further information:
Carl-Johan Dalsgaard, CEO
Tel: +46 70 975 98 63
E: carl-johan.dalsgaard@vicorepharma.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
| Vicore announces participation in investor meetings during June 2021 |
View original content:http://www.prnewswire.com/news-releases/vicore-announces-participation-in-investor-meetings-during-june-2021-301312172.html
SOURCE Vicore Pharma Holding AB
Company Codes: Bloomberg:VICO@SS, ISIN:SE0007577895, RICS:VICO.ST, Stockholm:VICO
